Results 231 to 240 of about 362,184 (267)

An efficient strategy for producing RNA‐free Nucleocapsid protein of SARS‐CoV‐2 for biochemical and structural investigations

FEBS Open Bio, Volume 15, Issue 11, Page 1762-1770, November 2025.
Cleavable N‐terminal Thioredoxin fusion enabled soluble expression and purification of otherwise insoluble SARS‐CoV‐2 Nucleocapsid (N) protein. A four‐step purification strategy yielded highly homogeneous, RNA‐free N protein. Binding assays showed high RNA affinity (Kd ~ 28 nm). The study will facilitate high‐resolution structural studies of N protein,
Shweta Singh, Gagan D. Gupta
wiley   +1 more source

Arteriovenous Thrombosis among Severe Acute Respiratory Syndrome Coronavirus 2 Infected Patients: An Observational Study at a University Hospital.

Ann Afr Med
AlAmri AS, AlShahrani MS, Hejazi TM, Abualola HA, Samarah AT, Almuaigel MF, AlDawsar FA, AlRashidi NS, AlGhamdi MA, Kabbani AH.   +9 more
europepmc   +1 more source

Coronavirus Disease 2019 Lineages in a Minimally Vaccinated Island Population: Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in Haiti. [PDF]

J Infect Dis
Mavian CN, Tagliamonte MS, Bassett M, Alam MT, Cash MN, Hitchings M, Louis R, Riva A, Zainabadi K, Deschamps MM, Liautaud B, Rouzier V, Fitzgerald DW, Pape JW, Morris JG, Salemi M.   +15 more
europepmc   +1 more source

Implementation of FTA Elute Card for Viral RNA Storage and Cost‐Effective Wastewater Surveillance

Advanced Sensor Research, Volume 4, Issue 11, November 2025.
A strategy is developed for room‐temperature storage of RNA from wastewater using FTA Elute cards, which allow for easy and portable transportation. FTA Elude cards provided a 15.4% recovery of the original RNA with cards, compared to only 0.5% recovery without cards.
Qingxin Hui, Yuwei Pan, David Cullen, Zhugen Yang   +3 more
wiley   +1 more source

Effect of Universal Masking on Non-Severe Acute Respiratory Syndrome Coronavirus 2 Healthcare-Associated Respiratory Viral Infections. [PDF]

Open Forum Infect Dis
Munigala S, Ching PR, Wood H, Waken RJ, Fox J, Gasama H, Russell R, Yarbrough ML, Warren DK.   +8 more
europepmc   +1 more source

The NSP5, ORF6 and NSP13 of SARS‐CoV‐2 Cooperate to Modulate Inflammatory Cell Death Activation

Advanced Science, Volume 12, Issue 41, November 6, 2025.
ZBP1 is capable of initiating a large cell death complex to induce programmed cell death during SARS‐CoV‐2 infection. However, SARS‐CoV‐2 can inhibit the activation of ZBP1‐mediated cell death by targeting key components of this complex. This suppression of ZBP1‐mediated cell death may account for the increased mortality observed in patients co ...
Huan Wang, Mengdi Liang, Jing Zhang, Hua Tong, Fenfen Zhang, Ying Liu, Pui Wang, Mengmeng Chang, Fei Han, Siwen Liu, Yongping Lin, Wenjun Song, Rajendra Karki, Peihui Wang, Honglin Chen, Yang Liu, Min Zheng   +16 more
wiley   +1 more source

Trajectories of Health-Related Quality of Life 2 Years After Mild/Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Pre-Omicron Era. [PDF]

Open Forum Infect Dis
Jacka BP, Cheng QL, Schiavone B, Darley DR, Kelleher AD, Dore GJ, Matthews GV.   +6 more
europepmc   +1 more source

Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB-Containing Vaccines. [PDF]

J Infect Dis
Chalkias S, McGhee N, Whatley JL, Essink B, Brosz A, Tomassini JE, Girard B, Edwards DK, Wu K, Nasir A, Lee D, Avena LE, Feng J, Deng W, Montefiori DC, Baden LR, Miller JM, Das R.   +17 more
europepmc   +1 more source

Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses, December 2019 to July 2020

Kacie Grimm, Paula Saá, Narayanaiah Cheedarla, Michael S Gerty, Jamel A. Groves, Roger Y. Dodd, John D. Roback, Susan L. Stramer   +7 more
openalex   +1 more source